Stoke Therapeutics, Inc. (STOK)

Last Three Months

29-Jan-24 -- 28-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

3

(1)

6

0

3

+1

0

+2

0

+3

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Feb-24 4:17 PM View:	13-Feb-24 Option Exercise $69.51K	Tzianabos Arthur Director		Stoke Therapeutics, Inc. - STOK	100% 0 to 31.74K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 4:21 PM View:	01-Apr-24 Sale (Planned) ($118.84K)	Ticho Barry Chief Medical Officer		Stoke Therapeutics, Inc. - STOK	(85%) 16.98K to 2.48K	0	0	--	--	Show Txns Hide Txns

19-Mar-24 8:30 PM View:	19-Mar-24 Option Sale ($68.00K)	Kaye Edward M. Md CEO Director		Stoke Therapeutics, Inc. - STOK	54% 45.0K to 69.35K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 4:19 PM View:	01-Apr-24 Sale (Planned) ($149.85K)	Nash Huw M. COO & CBO		Stoke Therapeutics, Inc. - STOK	(100%) 2.35K to 0	0	0	--	--	Show Txns Hide Txns

19-Mar-24 8:36 PM View:	19-Mar-24 Option Sale ($25.10K)	Tulipano Stephen J CFO		Stoke Therapeutics, Inc. - STOK	76% 11.76K to 20.75K	0	0	--	--	Show Txns Hide Txns

18-Apr-24 4:16 PM View:	17-Apr-24 Sale ($41.76M)	Skorpios Trust 10% Owner		Stoke Therapeutics, Inc. - STOK	(25%) 14.44M to 10.84M	0	0	--	--	Show Txns Hide Txns

01-Apr-24 4:14 PM View:	28-Mar-24 Sale (Planned) ($67.67K)	Allan Jonathan General Counsel & Corp Sec		Stoke Therapeutics, Inc. - STOK	0% 2.6K	0	0	--	--	Show Txns Hide Txns